medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2015, Number 01

<< Back Next >>

Ginecol Obstet Mex 2015; 83 (01)

Definitive contraception with Essure device: Single institutional experience on 517 procedures

Aparicio-Rodríguez-Miñón P, de la Fuente-Valero J, Martínez-Lara A, Alonso-García A, Sobrino-Mota V, Zapardiel-Gutiérrez I, Hernández-Aguado JJ

Language: Spanish
References: 23
Page: 16-22
PDF size: 383.79 Kb.


ABSTRACT

Objectives: To analyse the outcomes of patients undergoing Essure sterilization in a single institution, interns of complications and technique failure.
Patients and Methods: Retrospective descriptive study of 517 patients underwent definitive contraception with Essure device in outpatient hysteroscopy office without anesthesia and controlled at 3 months with abdominal radiography, ultrasonography and hysterosalpingography in selected cases.
Results: The success rates of the insertion of Essure was 96.8%, similar to data reported in the literature with 3.7% of vagal reactions, as most prevalent complication. 7 (1.35%) unintended pregnancies were observed.
Conclusions: Essure is a permanent birth control device, with high rate of successful insertion and a low rate of complications. Unintended pregnancies in our study are high and we must change the protocols of placement and monitoring, considering hysterosalpingography as a routine control test.


REFERENCES

  1. Mosher WD, Jones J. Use of contraception in the Unites States: 1982-2008. Vital Health Stat 2010;23:1-44.

  2. Kerin JF, Cooper JM, Price T, Herendael BJ, Cayuela-Font E, Cher D, Carignan CS, et al. Hysteroscopic sterilization using a micro-insert device: results of a multicentre phase II study. Hum Reprod 2003;18:1223-30.

  3. Cooper JM, Carignan CS, Cher D, Kerin JF. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol 2003;102:59-67.

  4. ESSURE Health Professional Website. Mechanism of action [accessed 19 November 2014]. Available from: http://www. essuremd.com/clinical-pathway

  5. Basinski CM. A review of clinical data for currently approved hysteroscopic sterilization procedures. Rev Obstet Gynecol 2010;3:101-10.

  6. Rodriguez AM, Kilic GS, Vu TP, Kuo YF, Breitkopf D, Snyder RR. Analysis of Tubal Patency After Essure Placement. J Minim Invasive Gynecol 2013;20:468-72.

  7. Peterson HB, Xia Z, Hughes J, Wilcox L, Tylor L, Trussell J. The risk of pregnanacy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 1996;174:1161-8.

  8. Cleary TP, Tepper NK, Cwiak C, Whiteman MK, Jamieson DJ, Marchbanks PA, Curtis KM. Pregnancies after hysteroscopic sterilization: a systematic review. Contraception 2013;87:539-48.

  9. Ubeda A, Labastida R, Dexeus S. Essure: a new device for hysteroscopic tubal sterilization in an outpatient setting. Fertil Steril 2004;82:196-9.

  10. Arjona J.E, Mino M, Cordon J, Povedano B, Pelegrin B, Castelo-Branco C. Satisfaction and tolerance with office hysteroscopic tubal sterilization. Fertil Steril 2008;90:1182- 6

  11. Povedano B, Arjona JE, Velasco E, Monserrat JA, Lorente J, Castelo-Branco C. Complications of hysteroscopic Essure® sterilisation: report on 4306 procedures performed in a single centre. BJOG 2012;119:795-9.

  12. Panel P, Grosdemouge I. Predictive factors of Essure implant placement failure: prospective, multicenter study of 495 patients. Fertil Steril 2010;93:29-34.

  13. Connor VF. Essure: a review six years later. J Minim Invasive Gynecol 2009;16:282-90.

  14. Veersema S, Vleugels M.P, Moolenaar L.M, Janssen C.A, Brolmann H.A. Unintended pregnancies after Essure sterilization in the Netherlands. Fertil Steril 2010;93:35-8.

  15. Jost S, Huchon C, Legendre G, Letohic A, Fernandez H, Panel P. Essure permanent birth control effectiveness: a seven-year survey. Eur J Obstet Gynecol Reprod Biol 2013;168:134-7.

  16. Ríos-Castillo JE, Velasco E, Arjona-Berral JE, Monserrat Jordán JA, Povedano-Cañizares B, Castelo-Branco C. Efficacy of Essure hysteroscopic sterilization- 5 years follow up of 1200 women. Gynecol Endocrinol 2013;29:580-2.

  17. Veersema S, Mol BW, Brölmann HA. Reproducibility of the interpretation of pelvic x-ray 3 months after hysteroscopic sterilization with Essure. Fertil Steril 2010;94:1202-7.

  18. Kerin JF, Levy BS. Ultrasound: an effective method for localization of the echogenic Essure sterilization micro-insert: correlation with radiologic evaluations. J Minim Invasive Gynecol 2005;12:50-4.

  19. Legendre G, Gervaise A, Levaillant JM, Faivre E, Deffieux X, Fernandez H. Assessment of three-dimensional ultrasound examination classification to check the position of the tubal sterilization microinsert. Fertil Steril 2010;94:2732-5.

  20. Legendre G, Levaillant JM, Faivre E, Deffieux X, Gervaise A, Fernandez H. 3D ultrasound to assess the position of tubal sterilization microinserts. Hum Reprod 2011;26:2683-9.

  21. Veersema S, Vleugels M, Koks C, Thurkow A, van der Vaart H, Brölmann H. Confirmation of Essure placement using transvaginal ultrasound. J Minim Invasive Gynecol 2011;18:164-8.

  22. Lazarus E, Lourenco AP, Casper S, Allen RH. Necessity of hysterosalpingography after Essure microinsert placement for contraception. AJR Am J Roentgenol 2012;198:1460-3.

  23. Shah V, Panay N, Williamson R, Hemingway A. Hysterosalpingogram: an essential examination following Essure hysteroscopic sterilisation. Br J Radiol 2011;84:805-12.




2020     |     www.medigraphic.com